Showing results for

Search instead for

medical-devices-list-2016-11-new-and-changes.xlsx

https://www.pharmac.govt.nz/assets/medical-devices-list-2016-11-new-and-changes.xlsx

ScheduleExport_NewAdditionsAndC CategoryName1 CategoryName2 CategoryName3 DeviceName1 DeviceName2 AdditionalInformation SupplierName UOM Packsize SupplyStatus SupplierProductCode BrandName EffectiveDate ExpiryDate Price SortDimension1 SortDimension2 GTIN Interventional Cardiology Guide Wires PCI Gui...

inpharmation-2011-06.pdf

https://www.pharmac.govt.nz/assets/inpharmation-2011-06.pdf

Pharmaceutical Management Agency JUNE 2011 Let the facts speak for themselves? When we live in a world where evidence is meant to trump opinion, you’d think facts were all that’s needed to convince others of the strength of an argument. But facts can be mistakenly connected to other facts, leading t...

reporting-2013-14-pharmac-performance-q4.pdf

https://www.pharmac.govt.nz/assets/reporting-2013-14-pharmac-performance-q4.pdf

PHARMAC Performance 2013/14 Performance data to 30 June 2014 Pharmaceutical budget management Combined Pharmaceutical Budget (CPB) 2013/14: $795 million. The planned CPB expenditure for the 2013/14 financial year was $800.19 million DHB CPB expenditure for the 2013/14 year was $11,904,623 over the a...

Schedule Online

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?code=A013701

<< Vitamins Online Pharmaceutical Schedule - August 2020

woc-community-event-evaluation-template.docx

https://www.pharmac.govt.nz/assets/woc-community-event-evaluation-template.docx

Community initiative event evaluation report template Event evaluation Date Location Event description Purpose/objective Other funders/sponsors and amount/s Branding used Participant information (general description) How many estimated attended Financial loss/profit Insights from event (qualitative ...

Schedule Online - Search > ibilex

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=ibilex

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Cephalosporins and Cephamycins Section B - Therapeutic Groups TG1 - Infections - Agents for Systemi... TG2 - Antibacterials TG3 - Cephalosporins and Cephamycins Cefalexin        Cap 250 mg Cephalexin ABM 2498871 $3.33 per...

Schedule Online - Search > salazopyrin

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=Salazopyrin

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Rectal and Colonic Anti-inflammatories Section B - Therapeutic Groups TG1 - Alimentary Tract and Metabolism TG2 - Antidiarrhoeals TG3 - Rectal and Colonic Anti-inflamm... Sulfasalazine        Tab 500 mg Salazopyrin 251615...

27 May 2003

https://www.pharmac.govt.nz/assets/notification-2012-08-07-filgrastim.pdf

7 August 2012 Decision to award sole supply for, and widen funded access to filgrastim PHARMAC is pleased to announce the approval of an agreement with Sandoz BioPharmaceuticals, a Novartis company. This was the subject of a consultation letter dated 19 June 2012. In summary, the effect of the decis...

Schedule Online - Search not found > sodium aurothiomalate

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=Sodium%20aurothiomalate&code=C1907012126

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Your search "sodium aurothiomalate" did not match any chemicals or brands. Please try one of the following: Check the spelling or try using different keywords. Search the PHARMAC website for " sodium aurothiomalate ", or ...

27 May 2003

https://www.pharmac.govt.nz/assets/consultation-2012-08-03-various-dhb-hospitals.pdf

3 August 2012 Proposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals PHARMAC is seeking feedback on a proposal relating to the establishment of a nationallyconsistent list of pharmaceuticals to be funded within DHB hospitals. This list would be published in Part II of Section H...

matariki-2016-hui-findings.pdf

https://www.pharmac.govt.nz/assets/matariki-2016-hui-findings.pdf

MATARIKI@PHARMAC FRIDAY 15 JULY 2016 RE/THINK Why did you have to ‘re/think’ the approach to the issue? What factors made it clear that a ‘re/think’ was needed? The way we live our lives is rapidly changing. New technology, new ways of thinking, new ways of looking. Google is the world’s best health...

ptac-haematology-subcommittee-minutes-2017-10.pdf

https://www.pharmac.govt.nz/assets/ptac-haematology-subcommittee-minutes-2017-10.pdf

Haematology Subcommittee of PTAC Meeting held 4 October 2017 (minutes for web publishing) The Haematology Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Note that this document ...

pharmac-stakeholder-survey-2015-overview.pdf

https://www.pharmac.govt.nz/assets/pharmac-stakeholder-survey-2015-overview.pdf

PHARMAC OVERVIEW 2015 COMPARISON WITH 2007 2015 STAKEHOLDER SURVEY FINDINGS The perception of suppliers, primary health care providers, health professional organisations and patient advocacy groups is that PHARMAC’s performance has improved substantially over the last seven years. During that time w...

erythropoietin-patient-info-sheet-maori.pdf

https://www.pharmac.govt.nz/assets/erythropoietin-patient-info-sheet-maori.pdf

Mōhiohio mā te hunga tūroro Erythropoietin (EPO) He aha ngā kōrero o tēnei mātārere? Kei tēnei pānui he kōrero mō Eprex hei āwhina i a koe ki te whakahaere i te huri ki tēnei momo EPO i muri i te 1 Mahuru 2014. He aha i huri ai te hua EPO e werohia ana ki roto i ahau? Kua nuku a PHARMAC ki tētahi wh...

erythropoietin-patient-info-sheet-samoan.pdf

https://www.pharmac.govt.nz/assets/erythropoietin-patient-info-sheet-samoan.pdf

Faamatalaga mo le tagata gasegase Erythropoietin (EPO) O ā ni faamatalaga i lenei pepa? O loo iai i lenei pepa ni faamatalaga i le Eprex e fesoasoani i le gafataulimaina o suiga o lenei ituaiga EPO e amata mai i le aso muamua o Setema 2014. Aisea e tatau ai ona sui le vailaau EPO lea ou te faaaogāin...

Schedule Online - Search > olbetam

https://www.pharmac.govt.nz/wwwtrs/ScheduleOnline.php?osq=olbetam

<< Section B - Therapeutic Groups Online Pharmaceutical Schedule - August 2020 Other Lipid-Modifying Agents Section B - Therapeutic Groups TG1 - Cardiovascular System TG2 - Lipid-Modifying Agents TG3 - Other Lipid-Modifying Agents Acipimox        Cap 250 mg Olbetam 609641 $21.56 per 30 Olbetam S29 2...

medical-devices-list-new-and-changes-2018-03.xlsx

https://www.pharmac.govt.nz/assets/medical-devices-list-new-and-changes-2018-03.xlsx

ScheduleExport_NewAdditionsAndC CategoryName1 CategoryName2 CategoryName3 DeviceName1 DeviceName2 AdditionalInformation SupplierName UOM Packsize SupplyStatus Weighting SupplierProductCode BrandName EffectiveDate ExpiryDate Price SortDimension1 SortDimension2 GTIN Interventional Cardiology Catheters...

pharmac-stakeholder-survey-2015-maori-stakeholders.pdf

https://www.pharmac.govt.nz/assets/pharmac-stakeholder-survey-2015-maori-stakeholders.pdf

MĀORI STAKEHOLDERS SUMMARY OF 2015 STAKEHOLDER SURVEY FINDINGS • 69 Māori stakeholders completed the quantitative survey. • Our Māori stakeholders have varied levels of engagement with PHARMAC. • There is strong belief in PHARMAC’s commitment to working with Māori. • PHARMAC is not seen to do enough...

SectionH.pdf

https://pharmac.govt.nz/2013/07/02/SectionH.pdf

The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals First edition effective 1 July 2013 New Zealand Pharmaceutical Schedule Guide to Section H listings ANATOMICAL HEADING Price (ex man. Excl. GST) $ Per Brand or Generic Manufacturer Generic name listed by therapeutic group and s...

Schedule-addendum-devices-2016-02.pdf

https://www.pharmac.govt.nz/assets/Schedule-addendum-devices-2016-02.pdf

Addendum to Part III of Section H of the Pharmaceutical Schedule Interventional Cardiology Price (ex man. excl GST) $ Per Brand Additional Information Supplier Access Devices Dilators DILATOR 4fr x 15cm $165.00 10 Dilator SJM Dilator St Jude 5fr x 15cm $165.00 10 Dilator SJM Dilator St Jude 5fr x 17...